A Phase IIb Placebo-Controlled Study of the Exon-Skipping Drug Eteplirsen in Subjects with Duchenne Muscular Dystrophy

被引：0
|
作者：
Mendell, Jerry
Rodino-Klapac, Louise
Sahenk, Zarife
Roush, Kandice
Bird, Lauren
Lowes, Linda
Alfano, Lindsay
Gomez, Ana Maria
Lewis, Sarah
Shontz, Kim
Flanigan, Kevin
Taylor, Laura
Walker, Christopher
Campbell, Katie
Allen, Hugh
Schilling, Christopher
Kean, John
Sazani, Peter
Kaye, Edward
机构：
来源：
NEUROLOGY | 2012年 / 79卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E87 / E88
页数：2
相关论文
共 50 条
  • [1] Exon-Skipping in Duchenne Muscular Dystrophy
    Takeda, Shin ichi
    Clemens, Paula R.
    Hoffman, Eric P.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 : S343 - S358
  • [2] Exon-skipping therapy for Duchenne muscular dystrophy
    Nakamura, Akinori
    Takeda, Shin'ichi
    NEUROPATHOLOGY, 2009, 29 (04) : 494 - 501
  • [3] Exon-skipping advances for Duchenne muscular dystrophy
    Echevarria, Lucia
    Aupy, Philippine
    Goyenvalle, Aurelie
    HUMAN MOLECULAR GENETICS, 2018, 27 (R2) : R163 - R172
  • [4] Exon-skipping therapy for Duchenne muscular dystrophy
    Nakamura, Akinori
    Takeda, Shin'ichi
    LANCET, 2011, 378 (9791): : 546 - 547
  • [5] Exon-skipping therapy for Duchenne muscular dystrophy
    Bhagavati, Satyakam
    LANCET, 2012, 379 (9811): : E10 - E10
  • [6] Pulmonary Function is Stable in Patients with Duchenne Muscular Dystrophy (DMD) Treated with Exon-Skipping Drug Eteplirsen in Phase 2b Study
    Mendell, J. R.
    Lowes, L. P.
    Alfano, L.
    Duda, P.
    Saoud, J.
    Kaye, E. M.
    ANNALS OF NEUROLOGY, 2014, 76 : S237 - S237
  • [7] Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMD
    Mendell, J. R.
    Rodino-Klapac, L.
    Sahenk, Z.
    Roush, K.
    Bird, L.
    Lowes, L. P.
    Alfano, L.
    Gomez, A. M.
    Lewis, S.
    Malik, V.
    Shontz, K.
    Flanigan, K. M.
    Kean, J. R.
    Allen, H. D.
    Shilling, C.
    Sazani, P.
    Saoud, J.
    Kaye, E. M.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 804 - 805
  • [8] Eteplirsen treatment for Duchenne muscular dystrophy Exon skipping and dystrophin production
    Charleston, Jay S.
    Schnell, Frederick J.
    Dworzak, Johannes
    Donoghue, Cas
    Lewis, Sarah
    Chen, Lei
    Young, G. David
    Milici, Anthony J.
    Voss, Jon
    DeAlwis, Uditha
    Wentworth, Bruce
    Rodino-Klapac, Louise R.
    Sahenk, Zarife
    Frank, Diane
    Mendell, Jerry R.
    NEUROLOGY, 2018, 90 (24) : E2146 - E2154
  • [9] Pulmonary function is stable through week 120 in patients with Duchenne muscular dystrophy (DMD) treated with exon-skipping drug eteplirsen in phase 2b study
    Mendell, J. R.
    Lowes, L. P.
    Alfano, L.
    Saoud, J.
    Duda, P.
    Kaye, E.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 828 - 829
  • [10] Exon-skipping approach shows potential in patients with Duchenne muscular dystrophy
    Nature Reviews Neurology, 2014, 10 (10) : 547 - 547
12345